Factors associated with smoking cessation medication use.

<p>OR: odds ratio; CI: confidence interval.</p><p>All variables in the univariate analyses were included in multivariate model.</p

Prevalence of smoking cessation medication use during 2005–2011.

<p>Prevalence of smoking cessation medication use during 2005–2011.</p

Prevalence of current smoking rate and quit attempt among current smokers.

<p>Prevalence of current smoking rate and quit attempt among current smokers.</p

Upgrades to the SPS-to-LHC Transfer Line Beam Stoppers for the LHC High-Luminosity Era

Each of the 3 km long transfer lines between the SPS and the LHC is equipped with two beam stoppers (TEDs), one at the beginning of the line and one close to the LHC injection point, which need to absorb the full transferred beam. The beam stoppers are used for setting up the SPS extractions and transfer lines with beam without having to inject into the LHC. Energy deposition and thermo-mechanical simulations have, however, shown that the TEDs will not be robust enough to safely absorb the high intensity beams foreseen for the high-luminosity LHC era. This paper will summarize the simulation results and limitations for upgrading the beam stoppers. An outline of the hardware upgrade strategy for the TEDs together with modifications to the SPS extraction interlock system to enforce intensity limitations for beam on the beam stoppers will be given

Kaplan-Meier curves for ischemic stroke incidence by neutrophil to lymphocyte ratio levels.

<p>Compared to subjects with NLR<1.5, subjects with 2.5≤NLR<3.0, 3.0≤NLR<3.5, and NLR≥3.5 had elevated risk for ischemic stroke incidence with aHR (95% CI) of 1.76 (1.09–2.84), 2.21 (1.21–4.04), and 2.96 (1.57–5.58), respectively, adjusted for major cardiovascular risk factors. Log-rank test showed P<0.0001.</p

Incremental predictive value of neutrophil to lymphocyte ratio for ischemic stroke incidence.

<p>Incremental predictive value of neutrophil to lymphocyte ratio for ischemic stroke incidence.</p

Characteristics of study population.

<p>Characteristics of study population.</p

Neutrophil to lymphocyte ratio and ischemic stroke incidence.

<p>Neutrophil to lymphocyte ratio and ischemic stroke incidence.</p